Security key
05380C102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 5,782,060
- Total 13F value
- $21,388,708
- Share change
- +782,774
- Put/Call ratio
- 0%
- SEC-reported price per share
- $3.70
- Number of holders
- 78
- Value change
- +$2,933,889
- Number of buys
- 50
- Number of sells
- 24
- Shares outstanding
- 30,540,782
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
78
Top holders
10
RCEL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
AVITA Medical, Inc. SEC filings
AVITA Medical, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05380C102
Recent filing periods:
Ownership snapshot
Top reported holders of RCEL - AVITA Medical, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 4.7%
13D/G row: VANGUARD GROUP INC
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 4.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
4.7%
BlackRock, Inc.
4.3%
GEODE CAPITAL MANAGEMENT, LLC
1.6%
STATE STREET CORP
1.4%
NORTHERN TRUST CORP
0.54%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13D/G
13F
The Vanguard Group · Company
|
4.7%
|
$4,988,131
1,444,579 shares
|
$0 | 31 Dec 2025 |
| BlackRock, Inc. |
13D/G
13F
Company
|
4.3%
|
$5,816,042
1,138,436 shares
|
$0 | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.6%
|
$1,653,642
479,185 shares
|
— | 31 Dec 2025 |
| STATE STREET CORP |
13F
Company
|
1.4%
|
$1,443,242
418,331 shares
|
— | 31 Dec 2025 |
| NORTHERN TRUST CORP |
13F
Company
|
0.54%
|
$563,740
163,403 shares
|
— | 31 Dec 2025 |
| MORGAN STANLEY |
13F
Company
|
0.49%
|
$516,517
149,715 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
78
Shares
5,782,060
Rows available
78
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
78
Q1 2026 holders
78
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend